secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0000950170-24-076333
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics dismisses RSM, engages Cherry Bekaert as auditor
---------------------------------------------------------------------

- Dismissed RSM US LLP as independent auditor on June 19, 2024; no disagreements reported.
- Appointed Cherry Bekaert LLP as successor independent auditor effective June 19, 2024.
- RSM's reports for FY 2023 and 2022 included going concern qualification.
- Change approved by Audit Committee; no reportable events in prior periods.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024076333/0000950170-24-076333-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024076333/tcrt-20240619.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-076333

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer